Compare GP & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GP | EVGN |
|---|---|---|
| Founded | 2010 | 1999 |
| Country | Canada | Israel |
| Employees | N/A | N/A |
| Industry | Construction/Ag Equipment/Trucks | Agricultural Chemicals |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4M | 7.4M |
| IPO Year | 2013 | 2013 |
| Metric | GP | EVGN |
|---|---|---|
| Price | $1.02 | $0.84 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $3.50 |
| AVG Volume (30 Days) | 17.6K | ★ 149.8K |
| Earning Date | 02-12-2026 | 03-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $73.33 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.23 | $0.73 |
| 52 Week High | $4.00 | $2.42 |
| Indicator | GP | EVGN |
|---|---|---|
| Relative Strength Index (RSI) | 47.46 | 43.80 |
| Support Level | $0.87 | $0.81 |
| Resistance Level | $1.07 | $1.23 |
| Average True Range (ATR) | 0.07 | 0.08 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 36.84 | 33.29 |
GreenPower Motor Co Inc is the manufacturer and distributor of all-electric charter, school, and city buses. The company offers electric-powered transit buses deploying electric drive and battery technologies with a lightweight chassis and low-floor body. Its product line includes all-electric transit buses, all-electric school buses, and shuttle buses. The company's buses depend on clean sheet design and utilize a custom battery management system and a proprietary flex power system for the drive motors. Geographically, the company generates a majority of its revenue from the United States of America and the rest from Canada.
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.